These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 9808609)
21. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480 [TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Latruffe N; Vamecq J Biochimie; 1997; 79(2-3):81-94. PubMed ID: 9209701 [TBL] [Abstract][Full Text] [Related]
23. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects. Hughes TA; Stentz F; Gettys T; Smith SR Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916 [TBL] [Abstract][Full Text] [Related]
24. Effects of fibrates on serum metabolic parameters. Elisaf M Curr Med Res Opin; 2002; 18(5):269-76. PubMed ID: 12240789 [TBL] [Abstract][Full Text] [Related]
27. [Anti-cholesterol agents, new therapeutic approaches]. Fruchart JC; Duriez P Ann Pharm Fr; 2004 Jan; 62(1):3-18. PubMed ID: 14747768 [TBL] [Abstract][Full Text] [Related]
28. Anti-hyperlipidemic properties of CM108 (a flavone derivative) in vitro and in vivo. Guo L; Hu WR; Lian JH; Ji W; Deng T; Qian M; Gong BQ Eur J Pharmacol; 2006 Dec; 551(1-3):80-6. PubMed ID: 17026988 [TBL] [Abstract][Full Text] [Related]
29. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. Mardones P; Pilon A; Bouly M; Duran D; Nishimoto T; Arai H; Kozarsky KF; Altayo M; Miquel JF; Luc G; Clavey V; Staels B; Rigotti A J Biol Chem; 2003 Mar; 278(10):7884-90. PubMed ID: 12511553 [TBL] [Abstract][Full Text] [Related]
30. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
34. Role of fibric acid derivatives in the management of risk factors for coronary heart disease. Després JP; Lemieux I; Robins SJ Drugs; 2004; 64(19):2177-98. PubMed ID: 15456334 [TBL] [Abstract][Full Text] [Related]
39. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Auwerx J; Schoonjans K; Fruchart JC; Staels B Atherosclerosis; 1996 Jul; 124 Suppl():S29-37. PubMed ID: 8831913 [TBL] [Abstract][Full Text] [Related]